
CARsgen Therapeutics Holdings Ltd
HKEX:2171

CARsgen Therapeutics Holdings Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.59
16.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does CARsgen Therapeutics Holdings Ltd hold over its rivals?
What risks and challenges
does CARsgen Therapeutics Holdings Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of CARsgen Therapeutics Holdings Ltd.
Provide an overview of the primary business activities
of CARsgen Therapeutics Holdings Ltd.
What unique competitive advantages
does CARsgen Therapeutics Holdings Ltd hold over its rivals?
What risks and challenges
does CARsgen Therapeutics Holdings Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for CARsgen Therapeutics Holdings Ltd.
Provide P/S
for CARsgen Therapeutics Holdings Ltd.
Provide P/E
for CARsgen Therapeutics Holdings Ltd.
Provide P/OCF
for CARsgen Therapeutics Holdings Ltd.
Provide P/FCFE
for CARsgen Therapeutics Holdings Ltd.
Provide P/B
for CARsgen Therapeutics Holdings Ltd.
Provide EV/S
for CARsgen Therapeutics Holdings Ltd.
Provide EV/GP
for CARsgen Therapeutics Holdings Ltd.
Provide EV/EBITDA
for CARsgen Therapeutics Holdings Ltd.
Provide EV/EBIT
for CARsgen Therapeutics Holdings Ltd.
Provide EV/OCF
for CARsgen Therapeutics Holdings Ltd.
Provide EV/FCFF
for CARsgen Therapeutics Holdings Ltd.
Provide EV/IC
for CARsgen Therapeutics Holdings Ltd.
Show me price targets
for CARsgen Therapeutics Holdings Ltd made by professional analysts.
What are the Revenue projections
for CARsgen Therapeutics Holdings Ltd?
How accurate were the past Revenue estimates
for CARsgen Therapeutics Holdings Ltd?
What are the Net Income projections
for CARsgen Therapeutics Holdings Ltd?
How accurate were the past Net Income estimates
for CARsgen Therapeutics Holdings Ltd?
What are the EPS projections
for CARsgen Therapeutics Holdings Ltd?
How accurate were the past EPS estimates
for CARsgen Therapeutics Holdings Ltd?
What are the EBIT projections
for CARsgen Therapeutics Holdings Ltd?
How accurate were the past EBIT estimates
for CARsgen Therapeutics Holdings Ltd?
Compare the revenue forecasts
for CARsgen Therapeutics Holdings Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of CARsgen Therapeutics Holdings Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of CARsgen Therapeutics Holdings Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of CARsgen Therapeutics Holdings Ltd compared to its peers.
Compare the P/E ratios
of CARsgen Therapeutics Holdings Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing CARsgen Therapeutics Holdings Ltd with its peers.
Analyze the financial leverage
of CARsgen Therapeutics Holdings Ltd compared to its main competitors.
Show all profitability ratios
for CARsgen Therapeutics Holdings Ltd.
Provide ROE
for CARsgen Therapeutics Holdings Ltd.
Provide ROA
for CARsgen Therapeutics Holdings Ltd.
Provide ROIC
for CARsgen Therapeutics Holdings Ltd.
Provide ROCE
for CARsgen Therapeutics Holdings Ltd.
Provide Gross Margin
for CARsgen Therapeutics Holdings Ltd.
Provide Operating Margin
for CARsgen Therapeutics Holdings Ltd.
Provide Net Margin
for CARsgen Therapeutics Holdings Ltd.
Provide FCF Margin
for CARsgen Therapeutics Holdings Ltd.
Show all solvency ratios
for CARsgen Therapeutics Holdings Ltd.
Provide D/E Ratio
for CARsgen Therapeutics Holdings Ltd.
Provide D/A Ratio
for CARsgen Therapeutics Holdings Ltd.
Provide Interest Coverage Ratio
for CARsgen Therapeutics Holdings Ltd.
Provide Altman Z-Score Ratio
for CARsgen Therapeutics Holdings Ltd.
Provide Quick Ratio
for CARsgen Therapeutics Holdings Ltd.
Provide Current Ratio
for CARsgen Therapeutics Holdings Ltd.
Provide Cash Ratio
for CARsgen Therapeutics Holdings Ltd.
What is the historical Revenue growth
over the last 5 years for CARsgen Therapeutics Holdings Ltd?
What is the historical Net Income growth
over the last 5 years for CARsgen Therapeutics Holdings Ltd?
What is the current Free Cash Flow
of CARsgen Therapeutics Holdings Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for CARsgen Therapeutics Holdings Ltd.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CN |
![]() |
CARsgen Therapeutics Holdings Ltd
HKEX:2171
|
7.3B HKD | 173.6 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 35 008 193.5 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
313.3B USD | 5.6 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
157.8B USD | 4.7 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
132.7B USD | 4.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.4B USD | 11.6 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 012.4 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
118.2B AUD | 4.8 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
62.6B USD | 4.4 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 19.4 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
31.5B EUR | 16.3 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
CN |
![]() |
CARsgen Therapeutics Holdings Ltd
HKEX:2171
|
Average P/S:
3 182 768.3
173.6
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
35 008 193.5
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
5.6
|
8%
|
0.7 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
4.7
|
4%
|
1.2 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.6
|
3%
|
1.5 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.6
|
10%
|
1.2 |
|
US |
E
|
Epizyme Inc
F:EPE
|
2 012.4
|
N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
4.8
|
7%
|
0.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
4.4
|
7%
|
0.6 |
|
US |
S
|
Seagen Inc
F:SGT
|
19.4
|
30%
|
0.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
16.3
|
37%
|
0.4 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.